1. Home
  2. Investing
  3. Stocks
  4. USA
  6. TransCode Therapeutics Inc (RNAZ)
  7. Quote


TransCode Therapeutics Stock Price

-0.21 (-7.69%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 64,199
Bid Price 2.52
Ask Price 2.75
News -
Day High 2.80


52 Week Range


Day Low 2.56
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
TransCode Therapeutics Inc RNAZ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.21 -7.69% 2.52 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.80 2.56 2.80 2.70 2.73
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
329 64,199 $ 2.64 $ 169,550 - 2.35 - 7.00
Last Trade Time Type Quantity Stock Price Currency
19:36:59 formt 100 $ 2.52 USD


Draw Mode:

TransCode Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 32.52M 12.90M 8.70M $ - $ - -0.32 -3.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 32.60%

more financials information »

TransCode Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RNAZ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.683.102.562.74104,678-0.16-5.97%
1 Month3.353.402.512.8588,621-0.83-24.78%
3 Months2.805.27862.353.954,189,230-0.28-10.0%
6 Months6.007.002.354.072,919,583-3.48-58.0%
1 Year6.007.002.354.072,919,583-3.48-58.0%
3 Years6.007.002.354.072,919,583-3.48-58.0%
5 Years6.007.002.354.072,919,583-3.48-58.0%

TransCode Therapeutics Description

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.

Your Recent History
TransCode ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.